Impact of hybrid FDG-PET/CT on gross tumor volume definition of cervical esophageal cancer: reducing interobserver variation
- PMID: 30864652
- PMCID: PMC6530614
- DOI: 10.1093/jrr/rrz004
Impact of hybrid FDG-PET/CT on gross tumor volume definition of cervical esophageal cancer: reducing interobserver variation
Abstract
Intensity-modulated radiation therapy is being increasingly used to treat cervical esophageal cancer (CEC); however, delineating the gross tumor volume (GTV) accurately is essential for its successful treatment. The use of computed tomography (CT) images to determine the GTV produces a large degree of interobserver variation. In this study, we evaluated whether the use of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET)/CT fused images reduced interobserver variation, compared with CT images alone, to determine the GTV in patients with CEC. FDG-PET/CT scans were obtained for 10 patients with CEC, imaged positioned on a flat tabletop with a pillow. Five radiation oncologists independently defined the GTV for the primary tumors using routine clinical data; they contoured the GTV based on CT images (GTVCT), followed by contouring based on FDG-PET/CT fused images (GTVPET/CT). To determine the geometric observer variation, we calculated the conformality index (CI) from the ratio of the intersection of the GTVs to their union. The interobserver CI was compared using Wilcoxon's signed rank test. The mean (±SD) interobserver CIs of GTVCT and GTVPET/CT were 0.39 ± 0.15 and 0.58 ± 0.10, respectively (P = 0.005). Our results suggested that FDG-PET/CT images reduced interobserver variation when determining the GTV in patients with CEC. FDG-PET/CT may increase the consistency of the radiographically determined GTV in patients with CEC.
Keywords: esophageal cancer; gross tumor volume; intensity-modulated radiation therapy; positron emission tomography; radiation therapy; radiotherapy planning.
© The Author(s) 2019. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology.
Figures

Similar articles
-
[F18] FDG-PET/CT for manual or semiautomated GTV delineation of the primary tumor for radiation therapy planning in patients with esophageal cancer: is it useful?Strahlenther Onkol. 2021 Sep;197(9):780-790. doi: 10.1007/s00066-020-01701-0. Epub 2020 Oct 26. Strahlenther Onkol. 2021. PMID: 33104815 Free PMC article.
-
The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1016-23. doi: 10.1016/j.ijrobp.2005.04.021. Epub 2005 Jun 24. Int J Radiat Oncol Biol Phys. 2005. PMID: 15979817
-
Impact of FDG-PET/CT fused imaging on tumor volume assessment of head-and-neck squamous cell carcinoma: intermethod and interobserver variations.Acta Radiol. 2008 Jul;49(6):693-9. doi: 10.1080/02841850802027034. Acta Radiol. 2008. PMID: 18568563
-
[Gross tumor volume (GTV) : Basics, methods, registration, limitations].Radiologe. 2018 Aug;58(8):722-729. doi: 10.1007/s00117-018-0416-2. Radiologe. 2018. PMID: 29947932 Review. German.
-
PET/CT Variants and Pitfalls in Gynecological Cancers.Semin Nucl Med. 2021 Nov;51(6):593-610. doi: 10.1053/j.semnuclmed.2021.06.006. Epub 2021 Jul 10. Semin Nucl Med. 2021. PMID: 34253332 Review.
Cited by
-
PET/CT and MR Improve Interobserver Agreement in Primary Tumor Determination for Radiotherapy in Esophageal Squamous Cell Cancer.Diagnostics (Basel). 2025 Mar 11;15(6):690. doi: 10.3390/diagnostics15060690. Diagnostics (Basel). 2025. PMID: 40150033 Free PMC article.
-
Impact of metal artifact reduction algorithm on gross tumor volume delineation in tonsillar cancer: reducing the interobserver variation.BMC Med Imaging. 2022 Sep 6;22(1):161. doi: 10.1186/s12880-022-00889-0. BMC Med Imaging. 2022. PMID: 36068498 Free PMC article.
-
The Role of MRI and PET/CT in Radiotherapy Target Volume Determination in Gastrointestinal Cancers-Review of the Literature.Cancers (Basel). 2023 May 29;15(11):2967. doi: 10.3390/cancers15112967. Cancers (Basel). 2023. PMID: 37296929 Free PMC article. Review.
-
Prevalence and risk factors for retropharyngeal and retro-styloid lymph node metastasis in hypopharyngeal carcinoma.Radiat Oncol. 2023 Aug 11;18(1):134. doi: 10.1186/s13014-023-02322-4. Radiat Oncol. 2023. PMID: 37568173 Free PMC article.
-
Prognostic Value of CT Imaging-Based Tumor Volume in Patients With Non-Surgical Esophageal Squamous Cell Carcinoma.Front Oncol. 2021 Jan 22;10:602681. doi: 10.3389/fonc.2020.602681. eCollection 2020. Front Oncol. 2021. PMID: 33575213 Free PMC article.
References
-
- Hoeben A, Polak J, Van De Voorde L et al. . Cervical esophageal cancer: a gap in cancer knowledge. Ann Oncol 2016;27:1664–74. - PubMed
-
- National Comprehensive Cancer Network NCCN Clinical Practice Guidelines in Oncology, Esophageal and Esophagogastric Junction Cancers (Version 2.2018). https://www.nccn.org/professionals/physician_gls/default.aspx (15 November 2018, date last accessed).
-
- Zenda S, Kojima T, Kato K et al. . Multicenter Phase 2 study of cisplatin and 5-fluorouracil with concurrent radiation therapy as an organ preservation approach in patients with squamous cell carcinoma of the cervical esophagus. Int J Radiat Oncol Biol Phys 2016;96:976–84. - PubMed
-
- Fenkell L, Kaminsky I, Breen S et al. . Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus. Radiother Oncol 2008;89:287–91. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical